MolecuLight Named Frost & Sullivan’s 2026 Global Company of the Year in Wound Imaging

October 28, 2026 -

Recognition highlights FDA approvals, improved patient outcomes, clinical evidence, integrated wound imaging, and commitment to customer support

PITTSBURGH, USA, October 28, 2026 – Today, MolecuLight announces that it has received Frost & Sullivan’s 2026 Global Company of the Year Award in the wound imaging industry. The recognition highlights MolecuLight’s

FDA Qualifies MolecuLightDX Wound Measurement as a Medical Device Development Tool (MDDT) for Evaluating New Products in Wound Care

January 29, 2026 -

Pittsburgh, USA, January 29, 2026 – MolecuLight today announced that its MolecuLightDX® wound measurement has been qualified by the U.S. Food and Drug Administration (FDA) as a Medical Device Development Tool (MDDT). The FDA’s MDDT program qualifies select, scientifically validated tools for use in medical device development

MolecuLight Showcases 10 Scientific Posters at SAWC Fall and Announces Upcoming Oxygenation Imaging on the MolecuLightDX®+ Platform

September 4, 2025 -

Toronto, CANADA – September 4, 2025 – MolecuLight Inc., the global leader in point-of-care fluorescence imaging for wound care, announces continued innovation in wound care technology and its presence at the Symposium on Advanced Wound Care (SAWC) Fall 2025, September 3–6 in Las Vegas, NV. Attendees can

Large Independent Randomized Controlled Trial Validates MolecuLight’s Transformative Impact on Wound Debridement, Showing Improved Outcomes and Lower Costs

August 27, 2025 -

TORONTO, ON and TAIPEI, TAIWAN, August 27, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, together with its Taiwanese distributor, Healtdeva Company Ltd., today announced the publication of the largest-ever randomized controlled trial (RCT) on its technology. Independently conducted and published

MolecuLight “Lights the Way to Equitable Wound Care” at National Medical Association Conference

July 18, 2025 -

Pittsburgh, USA – July 18, 2025 – MolecuLight Corp., a global pioneer in point-of-care fluorescence imaging for wound care, today announced its participation in the National Medical Association (NMA) Annual Convention and Scientific Assembly, being held from July 19-23, 2025, in Chicago, IL. Attendees are invited to

MolecuLight Appoints Dr. Julia Wright as Chief Medical Officer to Accelerate Clinical Adoption

July 10, 2025 -

TORONTO, CANADA – July 10, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, today announced the appointment of Dr. Julia Wright, MD, FACP, as its new Chief Medical Officer (CMO). Dr. Wright, an exceptionally respected physician with a distinguished 25-year career

Landmark Study Affirms MolecuLight’s Efficacy in Real-Time Bacterial Detection for Improved Wound Management

June 26, 2025 -

TORONTO, CANADA – June 26, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, proudly announces the publication of a landmark systematic review by researchers at Trinity College Dublin and the Royal College of Surgeons in Ireland (RCSI). Titled “The Clinical Utility

MolecuLight® Imaging Significantly Improves Outcomes and Cuts Costs for Deep Sternal Wound Infections in Taiwan Study; Signals Expansion into Surgical Applications

June 12, 2025 -

Toronto, CANADA and Taipei, TAIWAN – June 12, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for wound care, and its Taiwanese distributor, Healtdeva Company Ltd., congratulate researchers at Shuang-Ho Hospital in Taipei, Taiwan on their publication of groundbreaking findings using MolecuLight. The

MolecuLight to Showcase Innovative Wound Imaging Platform at the Society for Vascular Surgery Vascular Annual Meeting (VAM) 2025

June 4, 2025 -

Toronto, Canada – June 4, 2025 – MolecuLight Inc., a global pioneer in point-of-care fluorescence imaging for rapid detection of infection causing bacteria in wounds, is pleased to announce its participation in the Society for Vascular Surgery (SVS) Vascular Annual Meeting (VAM), taking place in New Orleans,